SUPN   $48.0601  0.63% Market Open

Supernus Pharmaceuticals, Inc.
Total Cash 403.21M
totalCashPerShare 7.302
EBITDA 144.03M
Total Debt 38.15M
quickRatio 1.882
currentRatio 2.195
Total Revenue 651.97M
debtToEquity 3.788
Revenue/Share 11.877
ROA 0.02891
ROE 0.06222
grossProfits
freeCashflow 162.93M
operatingCashflow 172.50M
earningsGrowth
revenueGrowth 0.142
grossMargins 0.89043
ebitdaMargins 0.22091
operatingMargins 0.16125
profitMargins 0.09159
enterpriseValue 1.55B
forwardPE 18.380953
floatShares 47.58M
sharesOutstanding 55.22M
sharesShort 6.77M
sharesShortPriorMonth 6.80M
dateShortInterest
sharesPercentSharesOut 0.12%
heldPercentInsiders 0.05%
heldPercentInstitutions 1.11%
Short Ratio help_outline 19.74%
shortPercentOfFloat 0.19%
impliedSharesOutstanding
bookValue 18.239
Price To Book help_outline 1.90
earningsQuarterlyGrowth
netIncomeToCommon 59.71M
trailingEps 1.07%
forwardEps 1.89%
enterpriseToEbitda 10.78
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.33 4Q 2024
institutionsCount 352
lastUpdated Nov. 6, 2024, 5:27 p.m.